Skip to main content

Table 2 Treatment modality distribution for residual lesions in “Involution & stabilization phase” and in “Post-involution phase”

From: Cost-utility analysis of propranolol versus corticosteroids in the treatment of proliferating infantile hemangioma in Italy

  Percentage patients receiving
Surgery resection 40.00%
Laser therapy 47.50%
Combination of two treatment* 12.50%
  1. *Combination = Surgery resection + Laser therapy